Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study (Q31076943)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study |
scientific article |
Statements
1 reference
Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study (English)
1 reference
1 reference
Isabelle Poizot-Martin
1 reference
Jean-Michel Molina
1 reference
Laurent Alric
1 reference
Lionel Piroth
1 reference
Caroline Solas
1 reference
Marc Bourlière
1 reference
Alissa Naqvi
1 reference
Eric Bellissant
1 reference
Rodolphe Garraffo
1 reference
Alain Renault
1 reference
Philippe Halfon
1 reference
Jade Ghosn
1 reference
ANRS HC27 BOCEPREVIH Study Group
1 reference
11 February 2016
1 reference
1 reference
17
1 reference
63-71
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference